| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | Chief Medical Officer | Common Stock | 91.5K | $266K | $2.91 | Jan 4, 2024 | Direct |
| Athira Pharma, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 0 | Jun 2, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Jan 4, 2024 | 1 | $0 | 4 | Jan 8, 2024 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Jun 2, 2023 | 3 | $29.4K | 4 | Jun 6, 2023 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Jan 19, 2023 | 1 | $0 | 4 | Jan 23, 2023 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Nov 15, 2022 | 1 | $16.4K | 4 | Nov 17, 2022 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Oct 13, 2022 | 2 | $10.6K | 4 | Oct 17, 2022 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Jun 28, 2022 | 1 | $28.8K | 4 | Jun 30, 2022 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Jun 22, 2022 | 2 | $12K | 4 | Jun 24, 2022 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Jan 18, 2022 | 2 | $10.4K | 4 | Jan 20, 2022 | Chief Medical Officer |
| ATHA | Athira Pharma, Inc. | Jul 21, 2021 | 5 | $68K | 4 | Jul 21, 2021 | Chief Medical Officer |